Showing 2679 results for "amyotrophic lateral sclerosis (ALS)"

Assistive Technology Helping ALS Patients

In this video from Philly Philms, watch how the evolution of technological devices are now providing a way for people with low mobility in their upper-body to be able to communicate with other people with the help of assistive technology. Amyotrophic lateral sclerosis (ALS)…

ALS May be Caused by Spreading Protein According to New Study

Scientists at UmeÃ¥ University have found that  superoxide dysmutase (SOD1), a protein that may cause amylotophic lateral sclerosis (ALS) spreads and clumps when injected into mice. The protein deposits also cause ALS-like symptoms. The report, titled “Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease” appeared May 3, 2016…

What is ALS?

In this video by NathanAndRose, watch Rose describe the amyotrophic lateral sclerosis disorder (ALS) and the American organization (ALS Association) which is searching for the cure. Learn more about ALS here: https://bit.ly/ALSNewsToday…

Biogen Promotes New Industry Fund for ALS Research with $5M Matching Gift

The Target ALS Foundation, a collaborative research consortium, received a $5 million matching-gift donation from Biogen to help establish the foundation’s new Industry Fund for ALS Research, supporting a network of private-public research laboratories working to develop effective treatments and, ideally, a cure for amyotrophic lateral sclerosis (ALS). “Biogen is deeply committed to ALS…

Neuronal Degeneration Linked to Decline in a Synaptic Protein

University of Bern researchers have discovered that the synaptic protein Homer-3 is linked to the death of Purkinje motor neurons in Spinocerebellar ataxia type 1 (SCA1), a motor neuron disease that, like amyotrophic lateral sclerosis (ALS), is characterized by extensive motor neuron loss. The study, titled “Impaired mTORC1-Dependent Expression of…

MediciNova to Present ALS Study at International Symposium

Biopharmaceutical MediciNova, Inc. will be present at the 26th International Symposium on ALS/MND (amyotrophic lateral sclerosis/motor neurone disease) to host a session on its therapeutic strategies for the treatment of Amyotrophic Lateral Sclerosis (ALS). The company announced it will participate in the symposium to…

ALS Organizations Launch Challenge To Improve Patients’ Communication

Two non-profit organizations, ALS Association and Prize4Life, have joined forces to launch a new challenge grant program called The ALS Assistive Technology Challenge. Inaugurated with an initial investment of close to $500,000, the new program intends to support research projects focused on new communication technology solutions for patients who suffer from…

Study Findings Reveal Key Genetic Piece of ALS And Dementia Puzzle

University of Toronto (UT) researchers have uncovered the main genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), a discovery that will lead to the development of new efficacious treatments. The work entitled, “Isoform-specific antibodies reveal distinct subcellular localizations of C9orf72 in amyotrophic lateral…